Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 538964 | NSE Symbol : | ISIN : INE947G01011 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
05-Feb-2025	12-Feb-2025	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Unaudited Financial Results For The Quarter And nine months Ended On December 31 2024 Outcome of Board Meeting for approval of Unaudited Financial results for the quarter and nine months ended on December 31, 2024 is attached (As per BSE Announcement Dated on 12/02/2025)
07-Nov-2024	14-Nov-2024	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited financial results for the quarter and half year ended on September 30 2024 In the attached revised outcome corrected misprint of EPS numbers In attached revised results corrected misprint of EPS numbers (As Per BSE Announcement Dated on 15.11.2024)
17-Jul-2024	24-Jul-2024	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve 1. the Unaudited Financial Results of the Company for the quarter ended on June 30 2024. 2.To decide the date time and venue of 43rd Annual General Meeting of the Company 3.notice convening 43rd Annual General Meeting of the Members of the Company. 4. Any other items of Agenda if any Unaudited Financial Results for the Quarter Ended on June-2024 is attached Announcement under Reg 30(LODR)-Change in Director Outcome of Board Meeting held on July 24, 2024 is attached (As per BSE Announcement Dated on 24/07/2024) In attached revised outcome corrected NRC committee constitution in annexure (As Per BSE Announcement Dated on 26.07.2024)
21-May-2024	28-May-2024	Accounts	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended on March 31 2024 together with the Directors Report together with the Directors Report. 2.To recommend final dividend for the year ended on March 31 2024 if any subject to approval of shareholders at the ensuing Annual General Meeting. 3.Appointment of Secretarial Auditor for the Financial Year 2024-25 4.Appointment of Internal Auditor for the FY 2024-25 5.Appointment of Cost Auditor for the FY 2024-25 6.any other items of Agenda if any Outcome of Board Meeting held on May 28, 2024 is attached Intimation for appointment of secretarial, internal and cost auditors for the FY 2024-25 is attached In earlier attached financial statement missed to attached auditors report inadvertently. There is no any other change (As Per BSE Announcement dated on 28.05.2024)
05-Feb-2024	12-Feb-2024	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31 2023 along with other items of agenda. Unaudited financial results of the Company along with limited review report issued by Statutory Auditor for the quarter and nine months ended on December 31, 2023 as per Regulation 33 of SEBI(LODR) Regulations, 2015 and other agenda items Unaudited Financial results for the quarter and nine months ended on December 31, 2023 (As Per BSE Announcement Dated on 12/02/2024)
30-Oct-2023	08-Nov-2023	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended on September 30 2023 along with other items of agenda if any. MERCURY LABORATORIES LIMITED has informed BSE about Board Meeting to be held on 08 Nov 2023 to consider financial statements for the period ended September 2023. Financial results / Other business. The meeting of Board of Directors held on November 08, 2023, the Board considered and approved following agenda items, 1. Unaudited financial results of the Company along with limited review report issued by Statutory Auditor for the quarter and half year ended on September 30, 2023 2. Mr. Saurabh Mittal has been promoted as Chief Operating Officer of the Company, Senior Management Personnel of the Company, with effect from, today, November 08, 2023. (As per BSE Announcement Dated on 08/11/2023)
28-Jul-2023	05-Aug-2023	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Unaudited financial results of the Company for the quarter ended on June 30 2023.
28-Apr-2023	05-May-2023	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2023 inter alia to consider and approve 1.Audited Annual Accounts of the Company for the financial year ended on March 31 2023 together with the Directors Report 2. Recommendation of Final Dividend If Any For Financial Year Ending 31St March 2023 3.To decide date time and venue of Annual General Meeting of the Members of the Company. Outcome of the Board Meeting - May 05, 2023_Mercury Laboratories Limited (As Per BSE Announcement dated on 05.05.2023)
04-Feb-2023	13-Feb-2023	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Intimation of Board Meeting for For approval of Unaudited Financial Results of the Company for the quarter ended on December 31 2022 and Other items of Agenda if any Unaudited Financial Results for the Quarter ended on December 31, 2022_Mercuay Laboratories Limited Outcome of the Board Meeting - February 13, 2023_Mercury Laboratories Limited (As Per BSE Announcement dated on 13.02.2023)
02-Nov-2022	11-Nov-2022	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve Unaudited financial results of the Company for the quarter ended on September 30 2022 and To consider and approve any other items of Agenda if any In thevmeeting of Board of Directors held on November 11, 2022 the Board of Directors approved following agenda Item. 1. The unaudited financial results of the Company along with limited review report issued by Statutory Auditor for the quarter and half year ended on September 30, 2022. 2. Creation of new facility for manufacturing of small volume parenteral having capacity of manufacturing of 75 million annually at Unit No 2 at Baroda - Halol Road, Jarodiapura, Jarod with an estimated cost of INR 30 Crores. (As Per BSE Announcement dated on 11.11.2022) Disclosure of information under Regulation 30(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 on Creation of new facility for manufacturing Small Volume Parenteral(SVPs) at Jarod (As Per BSE Announcement Dated 12.11.2022)
01-Aug-2022	09-Aug-2022	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve the Unaudited financial results of the Company for the quarter ended on June 30 2022 Outcome of the Board Meeting_MLL (As Per BSE Announcement Dated on 09.08.2022)
18-May-2022	26-May-2022	Accounts	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 inter alia to consider and approve 1. Audited Financial Results of the Company for the quarter and year ended on March 31 2022 together with the Directors Report 2.recommendation of final dividend for the year ended on March 31 2022 if any subject to approval of shareholders at the ensuing AGM 3.To consider / decide date time and venue of AGM of the Members of the Company 4.Closure of the Register of Members and Share Transfer Books in connection with Annual General Meeting of the Company. 5. To consider and approve notice convening 41st AGM of the Members of the Company. 6. To consider re-appointment of Mr. Rajendra R Shah (DIN:00257253) as a Managing Director of the Company with effect from 1st April 2023 7.To consider an appointment of M/s Mitesh Rana & Co. Company Secretaries as Secretarial Auditor of the Company for the Financial Year 22-23 8.To consider an appointment of M/s. K R & Associates as an Internal Auditor of the Company for the FY 22-23 and any other items of Agenda if any Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2021-22 subject to approval of shareholders at an ensuing Annual General Meeting. Mercury Laboratories Limited Audited Financial Results for the Quarter and Year ended March 31, 2022 (As Per BSE Announcement Dated on 26.05.2022) Communication to the Shareholders of the Company for the Deduction of Tax at Source (TDS) on Dividend payment during the Financial Year 2022-23 and Updation of their PAN, Email Address and Bank Account details_Mercury Laboratories Limited (As Per BSE Announcement Dated on 26.08.2022)
21-Jan-2022	31-Jan-2022	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter ended on December 31 2021 2. take note of resignation of Ms. Kinjal Khandelwal as Company Secretary of the Company 3. Other Items of Agenda An Independent Directors meeting will be held on January 31 2022. Mercury Laboratories Limited-Outcome of Board Meeting held on January 31, 2022 An Independent Directors Meeting also held on January 31,2022 (As Per BSE Announcement Dated on 31.01.2022)
12-Oct-2021	21-Oct-2021	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve 1. Un-audited financial results of the Company for the quarter ended on September 30, 2021 2. To consider and approve appointment of Mr. Ashish Vasavada as Chief Financial Officer of the company with the effect from October 21, 2021. 3. To consider and approve any other items of Agenda, if any The results so approved will be published pursuant to provisions of LODR. Further, as per the Company's Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company shall remain closed till the completion of 48 hours after declaration of financial results at the Board Meeting for all the Directors/officers/Designated Persons of the Company & shall re-open from the start of the business hours on October 24, 2021. You are therefore requested to take the above information on records Mercury Laboratories Limited -Outcome of Board Meeting held on October 21, 2021 The Meeting was commenced at 05:00 P.m. and concluded at 07:00 P.m. Mercury Laboratories Limited-Financial Results for the Quarter/Half year ended September 30, 2021. (As per BSE Announcement Dated on 21/10/2021)
02-Aug-2021	10-Aug-2021	Quarterly Results	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve the Un-audited financial results of the Company for the quarter ended on June 30, 2021 along with other items of agenda if any. Further, as per the Company's Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, the trading window for dealing in the securities of the Company shall remain closed till the completion of 48 hours after declaration of financial results at the Board Meeting for all the Directors/officers/Designated Persons of the Company & shall re-open from the start of the business hours on August 13, 2021. All the Directors/Officers/Designated Persons of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window. You are therefore requested to take the above information on records and disseminate information to stakeholders of the Company. Mercury Laboratories Limited -Outcome of Board Meeting held on August 10, 2021 The Meeting was commenced at 05:00 P.m. and concluded at 07:15 P.m. Mercury Laboratories Limited-Financial Results for the year ended June 30, 2021 (As per BSE Announcement Dated on 10/8/2021)

1 2

LOGIN HERE

Mercury Laboratories Ltd

Board Meeting